The corresponding tumor arraylet describes a global pattern of tumor-exclusive co-occurring CNAs, including most known GBM-associated changes in chromosome numbers and focal CNAs, as well as several previously unreported CNAs, including the biochemically putative drug target-encoding TLK2[14]. The gene discussed is TLK2; the disease is neoplasm.